Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

FENCFENC
16 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in FENNEC PHARMACEUTICALS INC

Bank of New York Mellon Corp holds 61,032 shares of FENC (FENNEC PHARMACEUTICALS INC), worth $656,098 as of 2026-Q2. The position was increased (+16.3% shares). FENC represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$656,098

Current Shares

61,032

Total Value Change

+$314,098

Total Shares Change

+15,166

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
61,032
+16.3%
$656,0980.0%$10.75
28
2026-Q1
Increased
52,462
+6.6%
$322,6430.0%$8.00
25
2025-Q4
Decreased
49,219
-5.8%
$378,9890.0%$7.76
0
2025-Q3
Increased
52,278
+0.9%
$489,3250.0%$9.09
24
2025-Q2
Decreased
51,812
-3.2%
$430,0430.0%$8.25
0
2025-Q1
Increased
53,506
+2.6%
$325,8490.0%$6.50
24
2024-Q4
Increased
52,128
+0.8%
$329,4460.0%$6.16
24
2024-Q3
Decreased
51,723
-24.7%
$258,6130.0%$5.20
0
2024-Q2
Increased
68,724
+42.8%
$419,9020.0%$6.11
32
2024-Q1
Increased
48,122
+4.6%
$535,1120.0%$11.12
25
2023-Q4
Decreased
45,993
-0.7%
$516,0380.0%$11.22
0
2023-Q3
Increased
46,332
+2.4%
$347,9500.0%$7.51
24
2023-Q2
New
45,242
-
$399,4830.0%$8.87
33
2021-Q2
Exited
0
-100.0%
$00.0%$7.52
0
2021-Q1
Decreased
44,912
-2.1%
$279,0000.0%$6.45
0
2020-Q4
New
45,866
-
$342,0000.0%$7.14
33

Other major holders of FENC: BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used